Continue Routine Screening After False-positive Mammo Result

Article

Screening mammograms, often associated with false-positive results in breast cancer-free women, may indicate underlying pathology that still could result in breast cancer, researchers said.

Screening mammograms, often associated with false-positive results in breast cancer-free women, may indicate underlying pathology that still could result in breast cancer, according to a study published today in the Journal of the National Cancer Institute.

It was not known if women whose tests show findings that lead to a false-positive may be at higher risk of developing breast cancer than women who do not test false-positive. After a diagnostic work-up eliminates a cancer diagnosis, the women are encouraged to continue with routine screening, but they may be reluctant to do so.

To evaluate the risk of breast cancer and ductal carcinoma in situ in women between the ages of 50 to 69 who had received false-positive mammography results, researchers from the University of Copenhagen gathered data from a long-standing Danish population-based screening mammography program that took place from 1991 to 2005.

The researchers found that women with false-positive results had a relative risk of breast cancer that was significantly higher than those who tested negative, even as long as six years after the initial screening.

In comparing women who tested negative with those who received false-positive results, the researchers found that the negative-finding women had an absolute cancer rate of 339/100,000 person-years at risk, while those with false-positive results had an absolute cancer risk of 583/100,000 person years at risk. Person-years is defined as the product of the number of years times the number of members of a population who have been affected by a certain condition.

“Based on the findings in this study, it may be beneficial to actively encourage women with false-positive tests to continue to attend regular screening,” the researchers concluded.

Recent Videos
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Related Content
© 2025 MJH Life Sciences

All rights reserved.